Cellular therapy is an exciting new field of medicine, where cells are used as living drugs that will continue to grow in the patient to exert and amplify their beneficial effects for the long term. This has been a big revolution in medicine and many patients around the world have been benefitting from the use of cells for treatment.
There are two main categories of cellular therapy: cellular immunotherapy and regenerative medicine.
The use of cellular therapy is growing and diversifying. Several new cellular therapy products have been approved by the United States Food and Drug Administration (FDA) in recent years, with more in the pipeline. The chimeric antigen receptor T cell (CAR T cell) is one such example. These are patient-derived T cells that undergo genetic modification to express an artificial T cell receptor against an antigen that is expressed on the surface of cancer cells.
Currently, there are five FDA-approved CAR T cells for use in haematological conditions such as:
Potential future indications(in development)